3 recruiting, 1 completed, 1 enrolling by invitation. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 2 |
Follow MDCECRO LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus CT3 Series Continuous Glucose Monitoring System: - Diabetes Mellitus | Enrolling by invitation | MDCECRO LLC | 72 | 2025-06-04 | 2025-08-22 | |
| Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions Peripheral Drug-eluting Stent System - Peripheral Arterial Disease | Not applicable | Recruiting | MDCECRO LLC | 153 | 2025-06-02 | 2025-09-12 |
| Observational Study of Venus P-Valve transcatheter pulmonary valve implantation (TPVI) - Right Ventricular Outflow Tract Dysfunction | Recruiting | Venus MedTech (HangZhou) Inc. | 200 | 2024-08-26 | 2025-01-24 | |
| The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region Gastric Bypass Stent System - Fibrosis, Liver | Not applicable | Recruiting | MDCECRO LLC | 10 | 2024-06-13 | 2025-05-08 |
| Post-market Clinical Follow-up Plan of StypCel™ Absorbable Hemostat Neurosurgery | Completed | Medprin Regenerative Medical Technologies Co., Ltd. | 108 | 2023-04-23 | 2025-09-30 |
Diabetes Mellitus (1) · Fibrosis (1) · Hemorrhage (1) · Peripheral Arterial Disease (1)
Latvia (3) · France (1) · Germany (1) · Italy (1) · Poland (1) · United Kingdom (1)
Kaspars Auslands, Dr. (1) · Shakeel A. Qureshi, MD (1)